<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">34927603</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">0974-7559</ISSN><JournalIssue CitedMedium="Internet"><Volume>59</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jan</Month><Day>15</Day></PubDate></JournalIssue><Title>Indian pediatrics</Title><ISOAbbreviation>Indian Pediatr</ISOAbbreviation></Journal><ArticleTitle>Coronavirus Disease 2019 (COVID-19) Vaccination for Children: Position Statement of Indian Academy of Pediatrics Advisory Committee on Vaccination and Immunization Practices.</ArticleTitle><Pagination><StartPage>51</StartPage><EndPage>57</EndPage><MedlinePgn>51-57</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S097475591600381</ELocationID><Abstract><AbstractText Label="JUSTIFICATION">Data generated after the first wave has revealed that some children with coronavirus 19 (COVID-19) can become seriously ill. Multi-inflammatory syndrome in children (MIS-C) and long COVID cause significant morbidity in children. Prolonged school closures and quarantine have played havoc with the psychosocial health of children. Many countries in the world have issued emergency use authorisation (EUA) of selected Covid-19 vaccines for use in children. In India, a Subject Expert Committee (SEC) has recommended the use of Covaxin (Bharat Biotech) for children from the ages of 2-18 years. The recommendation has been given to the Drugs Controller General of India (DCGI) for final approval.</AbstractText><AbstractText Label="OBJECTIVE">To provide an evidence-based document to guide the pediatricians on the recommendation to administer COVID vaccines to children, as and when they are available for use.</AbstractText><AbstractText Label="PROCESS">Formulation of key questions was done by the committee, followed by review of literature on epidemiology and burden of Covid-19 in children, review of the studies on COVID vaccines in children, and the IAP stand on Covid-19 vaccination in children. The available data was discussed in the ACVIP focused WhatsApp group followed by an online meeting on 24 October, 2021, wherein the document was discussed in detail and finalized.</AbstractText><AbstractText Label="RECOMMENDATIONS">The IAP supports the Government of India's decision to extend the COVID-19 vaccination program to children between 2-18 years of age. Children with high-risk conditions may be immunized on a priority basis. The IAP and its members should be a partner with the Government of India, in the implementation of this program and the surveillance that is necessary following the roll-out.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kasi</LastName><ForeName>Srinivas G</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>Kasi Clinic, 2nd Cross, 3rd Block, Jayanagar, Bengaluru, Karnataka. Correspondence to: Dr Srinivas G Kasi, Convener, ACVIP of IAP, Kasi Clinic, 2nd Cross, 3rd Block, Jayanagar, Bengaluru, Karnataka. sgkasi@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dhir</LastName><ForeName>Shashi Kant</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Guru Gobind Singh Medical College, Faridkot, Punjab.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Abhay</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Dr Abhay K Shah Children Hospital, Ahmedabad, Gujarat.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shivananda</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Fortis Hospital, Banneraghatta Road, Bengaluru, Karnataka.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verma</LastName><ForeName>Sanjay</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Pediatrics, PGIMER, Chandigarh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marathe</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Marathe Child Care Hospital, Nagpur, Maharashtra.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chatterjee</LastName><ForeName>Kripasindhu</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Santiniketan Medical College, Bolpur, West Bengal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agarwalla</LastName><ForeName>Sunil</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, SCB Medical College and Hospital, Cuttack, Odisha.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Srirampur</LastName><ForeName>Sanjay</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Aditya Super Speciality Hospital, Hyderabad, Telangana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalyani</LastName><ForeName>Srinivas</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Niloufer Hospital, Osmania Medical College, Hyderabad, Telangana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pemde</LastName><ForeName>Harish K</ForeName><Initials>HK</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Lady Hardinge Medical College, New Delhi.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balasubramanian</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Kanchi Kamakoti Childs Trust Hospital, Chennai, Tamil Nadu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Basavaraja</LastName><ForeName>G V</ForeName><Initials>GV</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, IGICH, Bengaluru, Karnataka.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parekh</LastName><ForeName>Bakul J</ForeName><Initials>BJ</Initials><AffiliationInfo><Affiliation>Bakul Parekh Hospital for Children, Mumbai, Maharashtra.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Remesh</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Apollo Adlux Hospital, Kochi, Kerala.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gupta</LastName><ForeName>Piyush</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University College of Medical Sciences, New Delhi.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>For Advisory Committee on Vaccines and Immunization Practices (ACVIP), Indian Academy of Pediatrics</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017065">Practice Guideline</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>12</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>India</Country><MedlineTA>Indian Pediatr</MedlineTA><NlmUniqueID>2985062R</NlmUniqueID><ISSNLinking>0019-6061</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C000705967">pediatric multisystem inflammatory disease, COVID-19 related</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D026683" MajorTopicYN="N">Advisory Committees</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007114" MajorTopicYN="N">Immunization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007115" MajorTopicYN="N">Immunization Schedule</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010372" MajorTopicYN="Y">Pediatrics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018746" MajorTopicYN="N">Systemic Inflammatory Response Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><i>Competing interests</i>: None stated.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>20</Day><Hour>8</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>2</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34927603</ArticleId><ArticleId IdType="pmc">PMC8821846</ArticleId><ArticleId IdType="pii">S097475591600381</ArticleId><ArticleId IdType="doi">10.1007/s13312-022-2421-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72/ 314 cases From the Chinese center for disease control and prevention. JAMA. 2020;323:1239&#x2013;42. doi: 10.1001/jama.2020.2648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.2648</ArticleId><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Ministry of Health and Family, Government of India. Graphical illustration of data from COVID-19 cases in India. National Centre for Disease 2020. Accessed November 19, 2020. Available from: https://ncdc.gov.in/dashboard.php</Citation></Reference><Reference><Citation>Delahoy MJ, Ujamaa D, Whitaker M, et al. Hospitalizations associated with COVID-19 among children and adolescents &#x2014; COVID-NET, 14 States, March 1, 2020-August 14, 2021. Morb mortal Wkly Rep. 2021;70:1255&#x2013;60. doi: 10.15585/mmwr.mm7036e2.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7036e2</ArticleId><ArticleId IdType="pmc">PMC8437052</ArticleId><ArticleId IdType="pubmed">34499627</ArticleId></ArticleIdList></Reference><Reference><Citation>Holder J. Children drive britain&#x2019;s longest-running covid surge. The New York Times [Internet]. 2021 Oct 29; Accessed November 19,2021. Available from: https://www.nytimes.com/interactive/2021/10/29/world/europe/uk-britain-covid-surge.html</Citation></Reference><Reference><Citation>Age-wise little change between first and second waves, Health Ministry data shows [Internet]. The Indian Express. 2021 [cited 2021 Dec 16]. Available from: https://indianexpress.com/article/india/age-wise-little-change-between-first-and-second-waves-health-ministry-data-shows-7360821/</Citation></Reference><Reference><Citation>Laxminarayan R, Wahl B, Dudala SR, et al. Epidemiology and transmission dynamics of COVID-19 in two Indian states. Science. 2020;370:691&#x2013;7. doi: 10.1126/science.abd7672.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd7672</ArticleId><ArticleId IdType="pmc">PMC7857399</ArticleId><ArticleId IdType="pubmed">33154136</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsankov BK, Allaire JM, Irvine MA, et al. Severe COVID-19 Infection and pediatric comorbidities: A systematic review and meta-analysis. Int J Infect Dis. 2021;103:246&#x2013;56. doi: 10.1016/j.ijid.2020.11.163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.11.163</ArticleId><ArticleId IdType="pmc">PMC7679116</ArticleId><ArticleId IdType="pubmed">33227520</ArticleId></ArticleIdList></Reference><Reference><Citation>Jat KR, Sankar J, Das RR, et al. Clinical profile and risk factors for severe disease in 402 children hospitalized with SARS-CoV-2 from India: Collaborative Indian Pediatric COVID Study Group. J Trop Pediatr. 2021;67:f&#x2013;ab048. doi: 10.1093/tropej/fmab048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/tropej/fmab048</ArticleId><ArticleId IdType="pmc">PMC8344837</ArticleId><ArticleId IdType="pubmed">34152424</ArticleId></ArticleIdList></Reference><Reference><Citation>Pande N, Save S, Kondekar A, et al. Clinical profile of children with sars-cov-2 infection from a dedicated covid-19 hospital in India. Current Pediatric Research. 2021;697&#x2013;703.</Citation></Reference><Reference><Citation>D Kitano T, Kitano M, Krueger C, et al. The differential impact of pediatric COVID-19 between high-income countries and low- and middle-income countries: A systematic review of fatality and ICU admission in children worldwide. PLoS One. 2021;16:e0246326. doi: 10.1371/journal.pone.0246326.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0246326</ArticleId><ArticleId IdType="pmc">PMC7845974</ArticleId><ArticleId IdType="pubmed">33513204</ArticleId></ArticleIdList></Reference><Reference><Citation>Takia L, Angurana SK, Nallasamy K, et al. Updated management protocol for multisystem inflammatory syndrome in children (MIS-C) J Trop Pediatr. 2021;67:f&#x2013;ab071. doi: 10.1093/tropej/fmab071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/tropej/fmab071</ArticleId><ArticleId IdType="pubmed">34414434</ArticleId></ArticleIdList></Reference><Reference><Citation>Bautista-Rodriguez C, Sanchez-de-Toledo J, Clark BC, et al. Multisystem inflammatory syndrome in children: An international survey. Pediatrics. 2021;147:e2020024554. doi: 10.1542/peds.2020-024554.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2020-024554</ArticleId><ArticleId IdType="pubmed">33234669</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiwari A, Rauf A, Kesavan S, et al. A cohort study of COVID-19 related multisystem inflammatory syndrome in children and adolescents from multiple tertiary care centres in south india. Annals of Rheumatic Diseases. 2021;915&#x2013;6.</Citation></Reference><Reference><Citation>Mehra B, Pandey M, Gupta D, et al. COVID-19 associated multisystem inflammatory syndrome in children: A multicentric retrospective cohort study. Indian J Crit Care Med. 2021;1174&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8645810</ArticleId><ArticleId IdType="pubmed">34916752</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, Espuny Pujol F, Munblit D, et al. Clinical characteristics, activity levels and mental health problems in children with long COVID: A survey of 510 children [Internet]. Preprints.2021.2021030271.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9248023</ArticleId><ArticleId IdType="pubmed">35360923</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M, Manoharan L, Elkheir N, et al. Characterising long COVID: a living systematic review. BMJ Glob Health. 2021;6:e005427. doi: 10.1136/bmjgh-2021-005427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Coronavirus (COVID-19) latest insights &#x2014; Office for National Statistics [Internet]. Accessed November 19,2021. Available from:https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19latestinsights/infections#long-covid</Citation></Reference><Reference><Citation>Bartley CM, Johns C, Ngo TT, et al. Anti-SARS-CoV-2 and autoantibody profiles in the cerebrospinal fluid of 3 teenaged patients with COVID-19 and subacute neuropsychiatric symptoms. JAMA Neurol. 2021;e213821.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8546622</ArticleId><ArticleId IdType="pubmed">34694339</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein E, Lipsitch M, Cevik M. On the effect of age on the transmission of SARS-CoV-2 in households, schools, and the community. J Infect Dis. 2021;223:362&#x2013;9. doi: 10.1093/infdis/jiaa691.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa691</ArticleId><ArticleId IdType="pmc">PMC7665686</ArticleId><ArticleId IdType="pubmed">33119738</ArticleId></ArticleIdList></Reference><Reference><Citation>Park YJ, Choe YJ, Park O, et al. Contact tracing during Coronavirus Disease Outbreak, South Korea, 2020. Emerg Infect Dis. 2020;26:2465&#x2013;8. doi: 10.3201/eid2610.201315.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2610.201315</ArticleId><ArticleId IdType="pmc">PMC7510731</ArticleId><ArticleId IdType="pubmed">32673193</ArticleId></ArticleIdList></Reference><Reference><Citation>Szablewski CM, Chang KT, Brown MM, et al. SARS-CoV-2 transmission and infection among attendees of an overnight camp &#x2014; Georgia, June 2020. Morb Mortal Wkly Rep. 2020;69:1023&#x2013;5. doi: 10.15585/mmwr.mm6931e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6931e1</ArticleId><ArticleId IdType="pmc">PMC7454898</ArticleId><ArticleId IdType="pubmed">32759921</ArticleId></ArticleIdList></Reference><Reference><Citation>Riemersma KK, Grogan BE, Kita-Yarbro A, et al. Shedding of infectious SARS-CoV-2 despite vaccination [Internet]. medRxiv. 2021; 2021.07.31.21261387.</Citation></Reference><Reference><Citation>Ghosh R, Dubey MJ, Chatterjee S, Dubey S. Impact of COVID-19 on children: Special focus on the psychosocial aspect. Minerva Pediatr. 2020;72:226&#x2013;35. doi: 10.23736/S0026-4946.20.05887-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/S0026-4946.20.05887-9</ArticleId><ArticleId IdType="pubmed">32613821</ArticleId></ArticleIdList></Reference><Reference><Citation>Chawla N, Tom A, Sen MS, Sagar R. Psychological impact of COVID-19 on children and adolescents: A systematic review. Indian J Psychol Med. 2021;43:294&#x2013;9. doi: 10.1177/02537176211021789.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/02537176211021789</ArticleId><ArticleId IdType="pmc">PMC8327877</ArticleId><ArticleId IdType="pubmed">34385721</ArticleId></ArticleIdList></Reference><Reference><Citation>Panda PK, Gupta J, Chowdhury SR, et al. Psychological and behavioral impact of lockdown and quarantine measures for COVID-19 pandemic on children, adolescents and caregivers: A systematic review and meta-analysis. J Trop Pediatr. 2021;67:f&#x2013;aa122.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7798512</ArticleId><ArticleId IdType="pubmed">33367907</ArticleId></ArticleIdList></Reference><Reference><Citation>Clemmensen C, Petersen MB, S&#xf8;rensen TIA. Will the COVID-19 pandemic worsen the obesity epidemic? Nat Rev Endocrinol. 2020;16:469&#x2013;70. doi: 10.1038/s41574-020-0387-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-020-0387-z</ArticleId><ArticleId IdType="pmc">PMC7342551</ArticleId><ArticleId IdType="pubmed">32641837</ArticleId></ArticleIdList></Reference><Reference><Citation>Randolph HE, Barreiro LB. Herd immunity: understanding COVID-19. Immunity. 2020;52:737&#x2013;41. doi: 10.1016/j.immuni.2020.04.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.04.012</ArticleId><ArticleId IdType="pmc">PMC7236739</ArticleId><ArticleId IdType="pubmed">32433946</ArticleId></ArticleIdList></Reference><Reference><Citation>Witberg G, Barda N, Hoss S, et al. Myocarditis after Covid-19 vaccination in a large health care organization. N Engl J Med. 2021;385:2132&#x2013;39. doi: 10.1056/NEJMoa2110737.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2110737</ArticleId><ArticleId IdType="pmc">PMC8531986</ArticleId><ArticleId IdType="pubmed">34614329</ArticleId></ArticleIdList></Reference><Reference><Citation>Pai M, Chan B, Stall NM, et al. Vaccine-induced immune thrombotic thrombocytopenia (VITT) following adenovirus vector COVID-19 vaccination [Internet]. Ontario COVID-19 Science Advisory Table; 2021 May [cited 2021 Nov 19]. Available from: https://covid19-sciencetable.ca/sciencebrief/vaccine-induced-immune-thrombotic-thrombocytopenia-vitt-following-adenovirus-vector-covid-19-vaccination</Citation></Reference><Reference><Citation>Frenck RW, Klein NP, Kitchin N, et al. Safety, immunogenicity, and efficacy of the BNT162b2 Covid-19 vaccine in adolescents. New Engl Med. 2021;385:239&#x2013;50. doi: 10.1056/NEJMoa2107456.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2107456</ArticleId><ArticleId IdType="pmc">PMC8174030</ArticleId><ArticleId IdType="pubmed">34043894</ArticleId></ArticleIdList></Reference><Reference><Citation>Hause AM, Gee J, Baggs J, et al. COVID-19 vaccine safety in adolescents aged 12&#x2013;17 years &#x2014; United States, December 14, 2020&#x2013;July 16, 2021. Morb Mortal Wkly Rep. 2021;70:1053&#x2013;8. doi: 10.15585/mmwr.mm7031e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7031e1</ArticleId><ArticleId IdType="pmc">PMC8367318</ArticleId><ArticleId IdType="pubmed">34351881</ArticleId></ArticleIdList></Reference><Reference><Citation>Walter EB, Talaat KR, Sabharwal C, et al. Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age. N Engl J Med. 2021; NEJMoa 2116298. Epub ahead of print.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8609605</ArticleId><ArticleId IdType="pubmed">34752019</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali K, Berman G, Zhou H, et al. Evaluation of mRNA-1273 SARS-CoV-2 vaccine in adolescents. N Engl J Med. 2021;NEJMoa2109522.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8385554</ArticleId><ArticleId IdType="pubmed">34379915</ArticleId></ArticleIdList></Reference><Reference><Citation>ModernaTX, Inc. A phase 2/3, two-part, open-label, dose-escalation, age de-escalation and randomized, observer-blind, placebo-controlled expansion study to evaluate the safety, tolerability, reactogenicity, and effectiveness of mRNA-1273 SARS-CoV-2 vaccine in healthy children 6 months to less than 12 years of age [Internet]. clinicaltrials.gov; 2021 Nov [cited 2021 Nov 18]. Report No.: NCT04796896. Available from: https://clinicaltrials.gov/ct2/show/NCT04796896</Citation></Reference><Reference><Citation>Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation. An Open Label Study With an Open Dose Selection Period to Assess the Safety, Tolerability and Immunogenicity of the Drug &#x201c;Gam-COVID-Vac, a Combined Vector Vaccine for the Prevention of Coronavirus Infection Caused by the SARS-CoV-2 Virus&#x201d;, With the Participation of Adolescent Volunteers [Internet]. clinical trials.gov; 2021 Sep [cited 2021 Nov 18]. Report No.: NCT04954092. Available from: https://clinicaltrials.gov/ct2/show/NCT04954092</Citation></Reference><Reference><Citation>Bharat Biotech International Limited. A Phase II/III, Open Label, Multicenter Study to Evaluate the Safety, Reactogenicity and Immunogenicity of the Whole-Virion Inactivated SARS-CoV-2 Vaccine (COVAXIN&#xae;) in Healthy Volunteers Ages d&#x201d;18 to e&#x201d; 2 Years. [Internet]. clinicaltrials.gov; 2021 Jul. Report No.: NCT04918797. Accessed November 19, 2020. Available from: https://clinicaltrials.gov/ct2/show/NCT04918797</Citation></Reference><Reference><Citation>CTRI [Internet]. Accessed November 19, 2020. Available from: http://ctri.nic.in/Clinicaltrials/showallp.php?mid1=51254&amp;EncHid=&amp;userName=ZyCoV-D</Citation></Reference><Reference><Citation>Reuters. India gives emergency approval for world&#x2019;s first COVID-19 DNA vaccine. Reuters [Internet]. 2021 Aug 20. Accessed November 19, 2020. Available from: https://www.reuters.com/business/healthcare-pharmaceuticals/india-approves-zydus-cadilas-covid-19-vaccine-emergency-use-2021-08-20/</Citation></Reference><Reference><Citation>CTRI [Internet]. Accessed November 19, 2020. Available from: http://ctri.nic.in/Clinicaltrials/showallp.php?mid1=49327&amp;EncHid=&amp;userName=covovax</Citation></Reference><Reference><Citation>CTRI [Internet]. Accessed November 19, 2020. Available from: http://ctri.nic.in/Clinicaltrials/showallp.php?mid1=60393&amp;EncHid=&amp;userName=corbevax</Citation></Reference><Reference><Citation>Johnson &amp; Johnson applies for Covid-19 vaccine study in Indian adolescents [Internet]. Hindustan Times. Accessed November 19, 2020. Available from: https://www.hindustantimes.com/india-news/johnson-johnson-applies-for-covid-19-vaccine-study-in-indian-adolescents-101629442683103.html</Citation></Reference><Reference><Citation>United Nations Development Programme Improving Vaccination Systems &#x2014; eVIN [Internet]. UNDP Accessed on Nov 19, 2021. Available from: https://www.in.undp.org/content/india/en/home/projects/gavil.html</Citation></Reference><Reference><Citation>67% surveyed Indians have developed antibodies against Coronavirus, 40 crore still at risk: Govt [Internet]. India Today. [cited 2021 Dec 16]. Available from: https://www.indiatoday.in/coronavirus-outbreak/story/fourth-serosurvey-result-67-percent-indians-developed-antibodies-against-covid19-1830443-2021-07-20</Citation></Reference><Reference><Citation>Cavanaugh AM, Spicer KB, Thoroughman D, et al. Reduced risk of reinfection with SARS-CoV-2 after COVID-19 vaccination &#x2014; Kentucky, May-June 2021. Morb Mortal Wkly Rep. 2021;70:1081&#x2013;3. doi: 10.15585/mmwr.mm7032e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7032e1</ArticleId><ArticleId IdType="pmc">PMC8360277</ArticleId><ArticleId IdType="pubmed">34383732</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozio CH, Grannis SJ, Naleway AL, et al. Laboratory-confirmed COVID-19 among adults hospitalized with COVID-19-Like illness with infection-induced or mRNA vaccine-induced SARS-CoV-2 immunity &#x2014; nine states, January-September 2021. Morb Mortal Wkly Rep. 2021;70:1539&#x2013;44. doi: 10.15585/mmwr.mm7044e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7044e1</ArticleId><ArticleId IdType="pmc">PMC8568091</ArticleId><ArticleId IdType="pubmed">34735425</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>